REFERENCES
- Jacobs D, Galetta S.Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol. 2002;13(6):347–51.
- Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumor? Ophthalmology. 1996;103:521–7.
- Mihatsch MJ, Steiner K, Abeywickrama KH, et al. Risk factors for the development of chronic Cyclosporine-nephrotoxicity. Clin Nephrol. 1988;29:165–75.
- Miescher PA, Favre H, Chatelanat F, Mihatsch MJ. Combined steroid- Cyclosporine treatment of chronic autoimmune diseases. Clinical results and assessment of nephrotoxicity by renal biopsy. Klin Wochenschr. 1987;65:727–36.
- Feutren G, Mihatsch MJ.Risk factors for Cyclosporine- induced nephrotoxicity in patients with autoimmune diseases. N Engl J Med. 1992;326:1654–60.
- Bielory L, Frohman PL. Low-dose Cyclosporine therapy of granulomatous optic neuropathy and orbitopathy. Ophthalmology. 1991;98:1732–5.
- Sánchez-Román J, Varela-Aguilar JM, Bravo-Ferrer J, et al.Idiopathic orbital myositis: treatment with Cyclosporine. Ann Rheum Dis. 1993;52:84–85.